Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
Clinical trial NCT02622958 · COMPLETED
Trial details
- NCT number
- NCT02622958
- Sponsor
- Pherin Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-10-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.